| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |